Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85649732 | 8564973 | 2 | F | 20120213 | 20160629 | 20120516 | 20160715 | PER | US-ALEXION-A201200298 | ALEXION | 14.36 | YR | M | Y | 105.60000 | KG | 20160715 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85649732 | 8564973 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||||
| 85649732 | 8564973 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 300 MG, SINGLE | 125166 | 300 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QD | ||||||
| 85649732 | 8564973 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||||
| 85649732 | 8564973 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 20 MG, 2 TAB, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 85649732 | 8564973 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | |||||||
| 85649732 | 8564973 | 6 | C | LASIX | FUROSEMIDE | 1 | Unknown | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 85649732 | 8564973 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
| 85649732 | 8564973 | 8 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, 2 TABS, QD | 0 | 25 | MG | TABLET | QD | ||||||
| 85649732 | 8564973 | 9 | C | CLONIDINE. | CLONIDINE | 1 | Unknown | 0.2 MG, BEDTIME | 0 | .2 | MG | TABLET | |||||||
| 85649732 | 8564973 | 10 | C | CLONIDINE. | CLONIDINE | 1 | Oral | 2 TAB, EVERY NIGHT | 0 | TABLET | |||||||||
| 85649732 | 8564973 | 11 | C | PROCARDIA | NIFEDIPINE | 1 | Oral | 1 CAP, Q6H, AS NEEDED | 0 | CAPSULE | Q6H | ||||||||
| 85649732 | 8564973 | 12 | C | PROCARDIA | NIFEDIPINE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | CAPSULE | |||||||
| 85649732 | 8564973 | 13 | C | CATAPRES /00171101/ | CLONIDINE | 1 | Topical | 0.3 MG, UNK | 0 | .3 | MG | TRANSDERMAL PATCH | |||||||
| 85649732 | 8564973 | 14 | C | AMOXICILLIN. | AMOXICILLIN | 1 | Oral | 1 CAP, QD | 0 | CAPSULE | QD | ||||||||
| 85649732 | 8564973 | 15 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | Oral | 5 MG, QD, GIVE 2 TABS | 0 | 5 | MG | TABLET | QD | ||||||
| 85649732 | 8564973 | 16 | C | CATAPRES /00171101/ | CLONIDINE | 1 | Oral | 0.2 MG, PRN AT BEDTIME | 0 | .2 | MG | TABLET | /yr | ||||||
| 85649732 | 8564973 | 17 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | Oral | 20 MG, EVERY MORNING | 0 | 20 | MG | CAPSULE | |||||||
| 85649732 | 8564973 | 18 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 1 TAB, QD | 0 | TABLET | QD | ||||||||
| 85649732 | 8564973 | 19 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | TABLET | |||||||
| 85649732 | 8564973 | 20 | C | OSCAL | CALCIUM CARBONATE | 1 | Oral | 1 TAB, QD | 0 | TABLET | BID | ||||||||
| 85649732 | 8564973 | 21 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 4 TABS OF 5MG, QD | 0 | TABLET | QD | ||||||||
| 85649732 | 8564973 | 22 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | |||||||
| 85649732 | 8564973 | 23 | C | CLONIDINE. | CLONIDINE | 1 | Topical | 0.3 MG, QD | 0 | .3 | MG | TRANSDERMAL PATCH | QD | ||||||
| 85649732 | 8564973 | 24 | C | CLONIDINE. | CLONIDINE | 1 | Topical | 1 PATCH TO THE SKIN, EVERY 7 DAYS | 0 | TRANSDERMAL PATCH | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 85649732 | 8564973 | 1 | Haemolytic uraemic syndrome |
| 85649732 | 8564973 | 4 | Hypertension |
| 85649732 | 8564973 | 6 | Hypertension |
| 85649732 | 8564973 | 7 | Hypertension |
| 85649732 | 8564973 | 8 | Hypertension |
| 85649732 | 8564973 | 9 | Hypertension |
| 85649732 | 8564973 | 11 | Blood pressure increased |
| 85649732 | 8564973 | 13 | Product used for unknown indication |
| 85649732 | 8564973 | 14 | Product used for unknown indication |
| 85649732 | 8564973 | 15 | Enuresis |
| 85649732 | 8564973 | 16 | Product used for unknown indication |
| 85649732 | 8564973 | 17 | Attention deficit/hyperactivity disorder |
| 85649732 | 8564973 | 18 | Product used for unknown indication |
| 85649732 | 8564973 | 20 | Product used for unknown indication |
| 85649732 | 8564973 | 21 | Product used for unknown indication |
| 85649732 | 8564973 | 23 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 85649732 | 8564973 | Incorrect dose administered | |
| 85649732 | 8564973 | Priapism | |
| 85649732 | 8564973 | Pruritus | |
| 85649732 | 8564973 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 85649732 | 8564973 | 1 | 20120122 | 0 | ||
| 85649732 | 8564973 | 2 | 20120122 | 20120122 | 0 | |
| 85649732 | 8564973 | 3 | 201202 | 0 | ||
| 85649732 | 8564973 | 9 | 20150605 | 0 | ||
| 85649732 | 8564973 | 10 | 20140903 | 0 | ||
| 85649732 | 8564973 | 13 | 20160209 | 0 | ||
| 85649732 | 8564973 | 17 | 20160105 | 0 | ||
| 85649732 | 8564973 | 19 | 20160105 | 0 | ||
| 85649732 | 8564973 | 20 | 20150605 | 0 | ||
| 85649732 | 8564973 | 21 | 20150605 | 0 | ||
| 85649732 | 8564973 | 24 | 20160105 | 0 |